Remove 2018 Remove Insurance Remove Manufacturing Remove Provider
article thumbnail

CMS proposes to Withdraw Trump Era Most Favored Nation (MFN) Drug Pricing Rule

FDA Law Blog

That proposal was withdrawn by the Trump HHS, but the notion of international reference pricing was subsequently incorporated in an October 2018 HHS Advance Notice of Proposed Rulemaking (ANPR) (see our post here ). Use of international reference pricing as a target for Medicare to negotiate prices with drug manufacturers appears in H.R.

Finance 52
article thumbnail

Even with Short-Term Health Insurance, his Colonoscopy Bill was $7,000

Physicians News Digest

By Julie Appleby Tim Winard knew he needed to buy health insurance when he left his management job in manufacturing to launch his own business. We were so nervous about not being on a company-provided plan,” Winard said. When he needed a colonoscopy, Winard, 57, called his insurance company. Then the bill came.